Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Melatonin wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
14 of 19 studies with measurable effects showed benefit.
Top outcomes
Verdict
Mostly mechanism / observational
2 of 2 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Melatonin and Skullcap have evidence — compare verdict strength side-by-side.
0.5-1mg
30-60 minutes before bed
Immediate-release tablet or sublingual
350-450mg dried herb OR 1-2ml tincture (1:5), up to 3x daily
Before bed for sleep, During day for anxiety as needed
Fresh plant tincture (most traditional)
Same night
1-3 days
Next morning
First week
30-60 minutes
30-60 minutes before bed
Melatonin in cancer treatment
The Cochrane database of systematic reviews (2025) · Meta analysis · n=126
We downgraded the certainty of the evidence because of high risk of bias, small sample size, the width of the 95% confidence interval, and indirectness due to inadequate reporting of cancer type.
Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease: A Systematic Review and Network Meta-Analysis
Journal of Alzheimer's disease : JAD (2024) · Meta analysis · n=4599
Melatonin may be a better potential disease-modifying treatment for cognitive decline in mild AD and MCI.
Melatonin for sleep disorders in people with autism: Systematic review and meta-analysis
Progress in neuro-psychopharmacology & biological psychiatry (2023) · Meta analysis · n=595
According to the global analysis, the wake after sleep onset and night awakening parameters were not statistically significant.
Baicalin and baicalein against myocardial ischemia-reperfusion injury: A review of the current documents
Tissue & cell (2025) · Systematic review
Research in both animal and cell models suggests that these flavonoids, especially baicalin, can restore cardiac health following MIRI, improving cardiac performance, and reducing cardiac damage.
Promising Role of the Scutellaria baicalensis Root Hydroxyflavone-Baicalein in the Prevention and Treatment of Human Diseases
International journal of molecular sciences (2023) · Systematic review
It has been documented that the extract of Baikal skullcap (Scutellaria baicalensis) has hepatoprotective, calming, antiallergic, and anti-inflammatory properties.
Wogonin and its analogs for the prevention and treatment of cancer: A systematic review
Phytotherapy research : PTR (2022) · Systematic review
WOG, in combination with established chemotherapeutic drugs, improves the efficacy of treatment and lowers toxicity.
Based on meta-analyses showing 7-12 minute reduction in sleep onset. Higher doses showed diminishing returns and increased morning grogginess. Sublingual forms may be more effective at lower doses.
Based on single crossover RCT (n=43) showing significant group effect for mood in healthy volunteers. Study population was relatively non-anxious (81% mildly anxious or less). Carryover effects noted. Limited evidence base requires further validation in clinical populations.
AI-estimated from published studies. Interpret as directional guidance.
Melatonin has a higher evidence score (9/10 vs 5.5/10) and wins in 2 of 3 categories.
For fall asleep faster, Melatonin has a higher relevance score (95 vs 70).
No known interactions between Melatonin and Skullcap have been documented in our database. However, always consult a healthcare provider before combining supplements.